InMed Pharmaceuticals Inc... (INM)
NASDAQ: INM
· Real-Time Price · USD
3.08
-0.01 (-0.32%)
At close: May 02, 2025, 3:57 PM
3.01
-2.43%
After-hours: May 02, 2025, 04:33 PM EDT
-0.32% (1D)
| Bid | 2.95 |
| Market Cap | 3.72M |
| Revenue (ttm) | 1.12B |
| Net Income (ttm) | -4.26B |
| EPS (ttm) | -12.42 |
| PE Ratio (ttm) | -0.25 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 3.15 |
| Volume | 15,054 |
| Avg. Volume (20D) | 46,530 |
| Open | 3.20 |
| Previous Close | 3.09 |
| Day's Range | 3.04 - 3.20 |
| 52-Week Range | 1.72 - 15.70 |
| Beta | 0.55 |
About INM
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of pain. In addition, it en...
Industry Biotechnology
Sector Healthcare
IPO Date May 5, 2014
Employees 13
Stock Exchange NASDAQ
Ticker Symbol INM
Website https://www.inmedpharma.com
3 months ago
+2.02%
InMed Pharmaceuticals shares are trading higher af...
Unlock content with
Pro Subscription
5 months ago
-15.75%
InMed Pharmaceuticals shares are trading lower after the company reported a year-over-year decrease in Q4 EPS results.
